OcuTerra Strengthens Board of Directors with Three New Key Appointments
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Business Wire
Biotech Leader Brent Saunders Named Chairman of BoardRobert Ruffolo, Ph.D, and Robin Steele Named Board Members BOSTON--(BUSINESS WIRE)--OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology drug development company focused on treating diabetic retinopathy earlier to preserve vision and avoid intravitreal injections, today announced the appointment of Brent Saunders, Robert Ruffolo, Ph.D., and Robin Steele to its Board of Directors. Brent Saunders will serve as Chairman and William H. Koster, Ph.D, will remain on the Board as Vice Chair.“The appointment of Brent as our Chairman and the addition of Bob and Robin to our Board underscores the momentum and growth of OcuTerra. A recognized biotech visionary and innovator, Brent has been instrumental in leading some of the most well-known companies to success,” said Kerrie Brady, Chief Executive Officer of OcuTerra. “In addition, we believe that’s Bob’s deep experience leading drug research and development which includ
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Acute Repetitive Seizures Market Predicted to Reach USD 7.94 Billion By 2032, With a Growth of 11.9% CAGR: Polaris Market Research [Yahoo! Finance]Yahoo! Finance
- Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Royal Bank of Canada from $12.00 to $11.00. They now have a "sector perform" rating on the stock.MarketBeat
- Fungal Keratitis Treatment Market Size Projections Exhibit a CAGR of 5.1%, Likely to Attain a Value of USD 1.48 Billion by 2033 [Yahoo! Finance]Yahoo! Finance
- Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards [Yahoo! Finance]Yahoo! Finance
- Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business AwardsPR Web
BHC
Earnings
- 2/22/24 - Miss
BHC
Sec Filings
- 4/4/24 - Form ARS
- 4/4/24 - Form DEFA14A
- 4/4/24 - Form DEF
- BHC's page on the SEC website